MSF has been using the tuberculosis (TB) drug bedaquiline for over a decade to treat people in our projects with drug-resistant TB. But the price of bedaquiline, made by Jonhson & Johnson, is too high to allow these new treatments to be rolled out widely. MSF is working to try to ensure more affordable access to bedaquiline for all in need.

свернуть